Search Results for: Q BioMed Announces Licensing Agreement
Articles
April 25, 2017
Q BioMed Announces Licensing Agreement April 25, 2017
Q BioMed Inc. (QBIO) and ASDERA LLC recently announced a licensing agreement that provides Q BioMed with the worldwide exclusive rights...
April 25, 2017
Q BioMed Announces Licensing Agreement April 25, 2017
Q BioMed Inc. (QBIO) and ASDERA LLC recently announced a licensing agreement that provides Q BioMed with the worldwide exclusive rights...
August 9, 2022
Fate Therapeutics Announces Preclinical Publication Highlighting Derivation of CD8αβ T Cells From TCR-CAR+ Induced Pluripotent Stem Cells August 9, 2022
Fate Therapeutics, Inc. recently announced the publication of preclinical study results demonstrating the successful generation, durable anti-tumor response, and functional...
October 6, 2015
ADVANCED DELIVERY DEVICES - Implantable Drug-Eluting Devices: A Novel Approach to Patient Care October 6, 2015
Samuel D. Trohman, MBA, Joey L. Glassco, Elena Draganoiu, PhD, and Carey Boyum present developmental and commercial examples of non-biodegradable drug-eluting devices, along with the versatile properties of thermoplastic polyurethanes for the development of effective drug delivery systems.
May 14, 2012
5/16/2012 May 14, 2012
Mucosis Announces Positive Data for Mimopath Platform Mucosis B.V. recently announced Phase I clinical data providing proof-of-concept that Mimopath-based mucosal...
